Cost-effectiveness analysis of using the UGT1A1 genotypeto increase irinotecan dose plus bevacizumab for metastatic colorectal cancer
碩士 === 高雄醫學大學 === 醫務管理暨醫療資訊學系碩士班 === 106 === Purpose: Colorectal cancer incidence rate rank is fourth and death rate ranks is second in the national. In Taiwan, per 100,000 people have 15.09 people die due to colorectal cancer. The UGT1A1 in human genes, and some may affect their function or perform...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2018
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/37h5ec |